1. AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials. (15th June 2017) Authors: Kavanaugh, A; Augustin, M; Lespessailles, E; Papp, KA; Paris, M; Chen, R; Gladman, DD; Pariser, DM; Peris, K Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0785 Consistent safety profile with up to 4 years of apremilast treatment: analysis of data from 1493 patients with psoriatic arthritis in 3 large, phase iii, long-term studies. (15th June 2017) Authors: Mease, PJ; Gladman, DD; Gomez-Reino, JJ; Hall, S; Kavanaugh, A; Lespessailles, E; Schett, G; Paris, M; Teng, L; Wollenhaupt, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0487 Apremilast is associated with long-term (4-YEAR) DAS-28 (CRP) remission and improvements in skin disease: results from a phase iii study in dmard/biologic-experienced patients with active psoriatic arthritis. (15th June 2017) Authors: Edwards, CJ; Blanco, FJ; Crowley, J; McIlraith, M; Paris, M; Delev, N; Teng, L; Birbara, CA Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Passively mode-locked diode-pumped Tm3+:YLF laser emitting at 1.91 µm using a GaAs-based SESAM. (9th March 2018) Authors: Tyazhev, A; Soulard, R; Godin, T; Paris, M; Brasse, G; Doualan, J-L; Braud, A; Moncorgé, R; Laroche, M; Camy, P; Hideur, A Journal: Laser physics letters Issue: Volume 15:Number 4(2018:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PS-004 Analysis of the use of psychotropic drugs and pharmacological interactions in spanish chronic psychiatric patients. (14th February 2016) Authors: Fernández-Ferreiro, A; Martinez-Bahamonde, F; Lopez-Lopez, A; Pazos-Simon, N; Guemas, E; Paris, M; Echarri-Arrieta, E; Gonzalez-Barcia, M; Suarez-Artime, P; Lamas, M Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. R-matrix analysis of reactions in the 9B compound system applied to the 7Li problem in BBN. Issue 1 (January 2016) Authors: Paris, M; Hale, G; Hayes-Sterbenz, A; Jungman, G Journal: Journal of physics Issue: Volume 665:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0436 Durability of apremilast response in patients with psoriatic arthritis: long-term (208-week) results from the palace 1 trial. (15th June 2017) Authors: Kavanaugh, A; Gladman, DD; Gomez-Reino, JJ; Hall, S; Lespessailles, E; Mease, PJ; Schett, G; McIlraith, M; Delev, N; Paris, M; Teng, L; Wollenhaupt, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The role of mobile apps for pregnancy and postnatal care in promoting maternal and child health. (20th October 2021) Authors: Brunelli, L; De Vita, C; Cenedese, F; Cinello, M; Paris, M; Samogizio, F; Bava, M; Dal Cin, M; Zanchiello, S; Stampalija, T Journal: European journal of public health Issue: Volume 31(2021)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗